Clinical Research Facility

Ashland, Kentucky 41101

We've found

2 trials

at this facility

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer

Status: Enrolling, Phase II
Updated: 7/6/2016

from

Ashland, KY

Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Ashland, KY

Use our guide to learn which trials are right for you!